Cargando…

Circulating tumour cells predict survival in gastric cancer patients: a meta-analysis

AIM OF THE STUDY: The prognostic value of the detection of circulating tumour cells (CTCs) in gastric cancer has been studied intensely in recent years. However, the application of different technologies led to inconsistent results between the studies. Here, we performed a meta-analysis of published...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hui-Yu, Wei, Jia, Zou, Zheng-Yun, Qian, Xiao-Ping, Liu, Bao-Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731451/ https://www.ncbi.nlm.nih.gov/pubmed/26843841 http://dx.doi.org/10.5114/wo.2015.56651

Ejemplares similares

Meta-analysis shows that circulating tumor cells including circulating microRNAs are useful to predict the survival of patients with gastric cancer
por: Zhang, Zhen-yu, et al.
Publicado: (2014)

Circulating resistin levels and obesity-related cancer risk: A meta-analysis
por: Gong, Wei-Jing, et al.
Publicado: (2016)

Modelling Circulating Tumour Cells for Personalised Survival Prediction in Metastatic Breast Cancer
por: Ascolani, Gianluca, et al.
Publicado: (2015)

A novel and validated nomogram to predict overall survival for gastric neuroendocrine neoplasms
por: Zhang, Sheng, et al.
Publicado: (2019)

Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
por: Bai, Kaixuan, et al.
Publicado: (2023)

Monitoring gastric cancer progression with circulating tumour DNA
por: Hamakawa, T, et al.
Publicado: (2015)

The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta-analysis
por: Wei, Hui, et al.
Publicado: (2019)

A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms
por: Cao, Long-Long, et al.
Publicado: (2016)

Preoperative Splenic Density for the Prediction of Survival and Adjuvant Chemotherapy Benefits in Gastric Cancer
por: Zhang, Wei-teng, et al.
Publicado: (2020)

Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003)

Diagnostic and prognostic value of circulating tumor DNA in gastric cancer: a meta-analysis
por: Gao, Yunhe, et al.
Publicado: (2016)

A seven-gene signature predicts overall survival of patients with colorectal cancer
por: Chen, Huarong, et al.
Publicado: (2016)

Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
por: Wang, Yan, et al.
Publicado: (2019)

Cumulative Score Based on Preoperative Fibrinogen and Pre-albumin Could Predict Long-term Survival for Patients with Resectable Gastric Cancer
por: Wu, Zhi-jun, et al.
Publicado: (2019)

Circulating Micrornas Predict Survival of Patients with Tumors of Glial Origin
por: A, Drusco, et al.
Publicado: (2018)

Quantification of mutant alleles in circulating tumor DNA can predict survival in lung cancer
por: Yang, Xue, et al.
Publicado: (2016)

Dynamic monitoring of circulating tumor DNA to predict prognosis and efficacy of adjuvant chemotherapy after resection of colorectal liver metastases
por: Wang, De-Shen, et al.
Publicado: (2021)

Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer
por: Jiang, Xiumei, et al.
Publicado: (2017)

Value of folate receptor-positive circulating tumour cells in the clinical management of indeterminate lung nodules: A non-invasive biomarker for predicting malignancy and tumour invasiveness
por: Zhou, Qianjun, et al.
Publicado: (2019)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin
por: Fu, Afu, et al.
Publicado: (2016)

The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer
por: Chen, Qi-Yue, et al.
Publicado: (2022)

A novel gene expression-based prognostic scoring system to predict survival in gastric cancer
por: Wang, Pin, et al.
Publicado: (2016)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

High FoxP3 expression in tumour cells predicts better survival in gastric cancer and its role in tumour microenvironment
por: Ma, G-F, et al.
Publicado: (2014)

Risk score based on expression of five novel genes predicts survival in soft tissue sarcoma
por: Gu, Hui-Yun, et al.
Publicado: (2020)

Prognostic value of LRRC4C in Colon and Gastric Cancers correlates with Tumour Microenvironment Immunity
por: Yang, XiaoFeng, et al.
Publicado: (2021)

The role of microRNA-608 polymorphism on the susceptibility and survival of cancer: a meta-analysis
por: Dai, Zhi-Ming, et al.
Publicado: (2018)

Association between PD-L1 Expression on Tumour-Infiltrating Lymphocytes and Overall Survival in Patients with Gastric Cancer
por: Fang, Wenfeng, et al.
Publicado: (2017)

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Prognostic Role of the Circulating Tumor Cells Detected by Cytological Methods in Gastric Cancer: A Meta-Analysis
por: Zou, Kun, et al.
Publicado: (2016)

Radiomics signature of computed tomography imaging for prediction of survival and chemotherapeutic benefits in gastric cancer
por: Jiang, Yuming, et al.
Publicado: (2018)

Bromodomain protein 4 is a novel predictor of survival for gastric carcinoma
por: Zhu, Yixin, et al.
Publicado: (2017)

A Prognostic Model Based on Circulating Tumour Cells is Useful for Identifying the Poorest Survival Outcome in Patients with Metastatic Colorectal Cancer
por: Chou, Wen-Chi, et al.
Publicado: (2018)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

Long-term prognostic impact of circulating tumour cells in gastric cancer patients
por: Ito, Hiroaki, et al.
Publicado: (2016)

GNA13 as a prognostic factor and mediator of gastric cancer progression
por: Zhang, Jia-Xing, et al.
Publicado: (2015)

Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis
por: Lin, Ju-Li, et al.
Publicado: (2020)

The role of tumour microenvironment in gastric cancer angiogenesis
por: Brzozowa, Marlena, et al.
Publicado: (2014)

Oxaliplatin-Based Regimen is Superior to Cisplatin-Based Regimen in Tumour Remission as First-line Chemotherapy for Advanced Gastric Cancer: A Meta-Analysis
por: Zhang, Fei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jeqh1d3r8bq2qh4hr2ar638p99